Biocon's Insulin Facility in Malaysia Classified as Voluntary Action Indicated by U.S. FDA Jan. 12, 2025, 12:07 p.m. The U.S. FDA has classified Biocon Biologics’ insulin facilities in Johor Bahru, Malaysia as Voluntary Action Indicated (VAI).This classification follows a cGMP (current Good Manufac… Unlock the Full Filing And Lot More Access premium insights and stay ahead of the market with Dzambhala Pro. Learn More